Localization of epidermal sphingolipid synthesis and serine palmitoyl transferase activity: alterations imposed by permeability barrier requirements
- PMID: 7598529
- DOI: 10.1007/BF01105075
Localization of epidermal sphingolipid synthesis and serine palmitoyl transferase activity: alterations imposed by permeability barrier requirements
Abstract
Sphingolipids, the predominant lipid species in mammalian stratum corneum play, a central role in permeability barrier homeostatis. Prior studies have shown that the epidermis synthesizes abundant sphingolipids, a process regulated by barrier requirements, and that inhibition of sphingolipid synthesis interferes with barrier homeostasis. To investigate further the relationship between epidermal sphingolipid metabolism and barrier function, we localized sphingolipid synthetic activity in murine epidermis under basal conditions, and following acute (acetone treatment) or chronic (essential fatty acid deficiency, EFAD) barrier perturbation, using dithiothreitol and/or the staphylococcal epidermolytic toxin to isolate the lower from the outer epidermis. Under basal conditions, both the activity of serine palmitoyl transferase (SPT), the rate-limiting enzyme of sphingolipid synthesis, and the rates of 3H-H2O incorporation into sphingolipids were nearly equivalent in the lower and the outer epidermis. Following acute barrier perturbation, SPT activity increased significantly in both the lower (35%; P < 0.05) and the outer epidermal layers (60%; P < 0.01). The rates of 3H-H2O incorporation into each major sphingolipid family, including ceramides, glucosylceramides and sphingomyelin, increased significantly in both the lower and the outer epidermis of treated flanks after acute barrier disruption. Finally, SPT activity was modestly elevated (20%; P < 0.01) in the lower but not in the outer epidermis of EFAD animals. These studies demonstrate the ability of both lower and outer epidermal cells to generate sphingolipids, and that permeability barrier homeostatic mechanisms appear to differentially regulate SPT activity and sphingolipid synthesis in the lower and the outer epidermis in response to acute and chronic barrier perturbation.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation.J Clin Invest. 1991 Oct;88(4):1338-45. doi: 10.1172/JCI115439. J Clin Invest. 1991. PMID: 1918384 Free PMC article.
-
Regulation of epidermal sphingolipid synthesis by permeability barrier function.J Lipid Res. 1991 Jul;32(7):1151-8. J Lipid Res. 1991. PMID: 1940639
-
Barrier function regulates epidermal lipid and DNA synthesis.Br J Dermatol. 1993 May;128(5):473-82. doi: 10.1111/j.1365-2133.1993.tb00222.x. Br J Dermatol. 1993. PMID: 8504036 Review.
-
Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier.Br J Dermatol. 2000 Sep;143(3):524-31. doi: 10.1111/j.1365-2133.2000.03705.x. Br J Dermatol. 2000. PMID: 10971324
-
Sphingolipid synthetic pathways are major regulators of lipid homeostasis.Adv Exp Med Biol. 2011;721:139-48. doi: 10.1007/978-1-4614-0650-1_9. Adv Exp Med Biol. 2011. PMID: 21910087 Review.
Cited by
-
A study on altered expression of serine palmitoyltransferase and ceramidase in psoriatic skin lesion.J Korean Med Sci. 2007 Oct;22(5):862-7. doi: 10.3346/jkms.2007.22.5.862. J Korean Med Sci. 2007. PMID: 17982236 Free PMC article.
-
Glucosylceramides stimulate murine epidermal hyperproliferation.J Clin Invest. 1995 Jun;95(6):2903-9. doi: 10.1172/JCI117997. J Clin Invest. 1995. PMID: 7769132 Free PMC article.
-
Activation of TLR3 in keratinocytes increases expression of genes involved in formation of the epidermis, lipid accumulation, and epidermal organelles.J Invest Dermatol. 2013 Aug;133(8):2031-40. doi: 10.1038/jid.2013.39. Epub 2013 Feb 28. J Invest Dermatol. 2013. PMID: 23353987 Free PMC article.
-
Topical effects of N-acetyl-L-hydroxyproline on ceramide synthesis and alleviation of pruritus.Clin Cosmet Investig Dermatol. 2013;6:43-9. doi: 10.2147/CCID.S39370. Epub 2013 Feb 12. Clin Cosmet Investig Dermatol. 2013. PMID: 23430142 Free PMC article.